Information on the Target
Monte Nido & Affiliates, founded in 1996, is a prominent provider of eating disorder treatment in the United States. With over 45 facilities and five distinct brands operating across 15 states, the Company has established itself as a leader in the field. Monte Nido employs a vertically integrated treatment model, delivering care through an extensive range of services, including inpatient, residential, partial hospitalization, and intensive outpatient programs. This comprehensive approach allows the Company to cater to the diverse needs of its patients, focusing primarily on adolescents and young adults who struggle with eating disorders.
Monte Nido has garnered a reputation for high-quality clinical outcomes, underscored by its commitment to individualized patient care. Its programs specifically address the unique challenges faced by young females, who disproportionately experience eating disorders, often in conjunction with other mental health and social issues. As a trusted provider, Monte Nido plays a critical role in offering effective treatment solutions for individuals seeking recovery.
Industry Overview in the Target’s Specific Country
The mental health landscape in the United States has seen significant changes in recent years, particularly following the COVID-19 pandemic. The incidence of eating disorders has escalated, exacerbated by factors such as social isolation and increased stress. As a result, the demand for services related to eating disorder treatment has surged, highlighting a pressing need for accessible care solutions.
Despite growing awareness and efforts to de-stigmatize mental health issues, challenges persist in the form of limited access to quality care. Many individuals and their families find themselves grappling with a healthcare system that often falls short of meeting their urgent needs. The demand for eating disorder treatment continues to outstrip supply, underscoring an urgent gap that companies like Monte Nido aim to fill.
Furthermore, there have been notable strides made in promoting mental health awareness, particularly among adolescents and young adults. Schools, communities, and healthcare providers are increasingly prioritizing mental health education and resources, paving the way for a more informed public. Nevertheless, the gap between demand and accessible treatment options remains a critical concern that calls for strategic investments in this sector.
The growing recognition of mental health issues, alongside legislative efforts aimed at improving insurance coverage for eating disorder treatments, further points to a favorable environment for investment in healthcare services focused on behavioral health. These factors create a landscape ripe for innovation and expansion, making it a pivotal time for companies dedicated to addressing these pressing needs.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
The Rationale Behind the Deal
The acquisition of Monte Nido by Revelstoke Capital Partners serves as a strategic response to the increasing demand for eating disorder treatment services. As outlined by Revelstoke’s Partner, Andrew Welch, the firm aims to bolster Monte Nido’s mission to provide high-quality care by leveraging its extensive capital, resources, and expertise in healthcare services. The partnership is poised to enhance the Company's operational capabilities and expand its reach, ensuring that more communities can access necessary treatment options.
Moreover, the collaboration is positioned to accelerate Monte Nido’s growth trajectory through potential acquisitions and the establishment of new facilities. This investment reflects Revelstoke’s ongoing commitment to improving patient outcomes and expanding access to behavioral healthcare services, making it a timely and strategic move in the evolving mental health landscape.
Information About the Investor
Revelstoke Capital Partners is a Denver-based private equity firm focused on healthcare services and technology investments. Since its inception in 2013, Revelstoke has distinguished itself in the market by completing 165 acquisitions, which include 25 platform companies and 140 add-on acquisitions, amounting to approximately $4.8 billion in assets under management. The firm prides itself on collaborating with entrepreneurs and management teams to implement disciplined growth strategies, both organically and through acquisitions.
With a keen focus on behavioral healthcare, Revelstoke has developed substantial expertise in the sector, seeing it as an opportunity to create significant positive impact while achieving strong financial returns. The firm’s diligent approach to investment and its history of successful partnerships positions it as a competent facilitator of growth for organizations like Monte Nido, ensuring that the needs of those seeking treatment are met effectively.
View of Dealert
The acquisition of Monte Nido by Revelstoke Capital Partners represents a promising investment opportunity in the healthcare sector. The growing incidence of eating disorders and the pressing need for accessible treatment options align both the Company and the investor with a critical market demand that shows strong potential for expansion. By addressing the significant gap in service provision, Monte Nido is well-positioned for growth in the evolving mental health landscape.
Moreover, Revelstoke's substantial experience and resources provide Monte Nido with the necessary support to scale its operations effectively. The potential for rapid expansion, including the opening of new facilities and strategic acquisitions, indicates that this partnership could yield high returns while enhancing patient access to quality care treatments.
However, it is important to monitor market dynamics closely. As the mental health sector continues to evolve, staying ahead of trends and adapting to shifts in demand will be crucial for long-term success. Nonetheless, the partnership between Revelstoke and Monte Nido appears to be strategically sound, making it a likely positive investment for both parties involved.
In conclusion, this acquisition not only stands to benefit the stakeholders directly involved, but it also promises to provide vital resources to individuals struggling with eating disorders, marking an essential step forward in enhancing the availability of comprehensive care solutions across the nation.
Similar Deals
Aspen Dental Management, Inc. → ClearChoice Management Services
2023
ARCHIMED → NAMSA
2023
Keystone Capital → Foundation Dental Partners
2023
Ares Management Corporation and Leonard Green & Partners → Press Ganey Associates, Inc.
2023
One Equity Partners → Prime Time Healthcare
2023
Kaiser Permanente → Renown Health
2026
Patient Square Capital → Premier Inc.
2026
Heartland Dental → Smile Design Dentistry
2025
ChristianaCare → Crozer Health outpatient locations
2025
Revelstoke Capital Partners
invested in
Monte Nido & Affiliates
in 2022
in a Leveraged Buyout (LBO) deal